Doherty Catherine T. 4
4 · QUEST DIAGNOSTICS INC · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Quest Diagnostics (DGX) EVP Catherine Doherty Receives Award, Sells Shares
What Happened
Catherine T. Doherty, EVP, Regional Businesses at Quest Diagnostics (DGX), received 11,364 shares on 2026-03-04 in settlement of a performance stock award (valued at $2,328,029 at $204.86/share). To cover tax withholding from that settlement she surrendered 5,806 shares back to the company (value $1,189,417). On 2026-03-05 she sold 5,558 shares in an open-market transaction at $206.21/share for $1,146,115 (reported sale under a Rule 10b5-1 plan).
Key Details
- Transaction dates and prices:
- 2026-03-04: Award settlement — 11,364 shares @ $204.86 = $2,328,029 (F1)
- 2026-03-04: Tax withholding — 5,806 shares @ $204.86 = $1,189,417 (F2)
- 2026-03-05: Open-market sale — 5,558 shares @ $206.21 = $1,146,115 (F3)
- Shares owned after the transactions: not specified in the supplied filing.
- Notable footnotes:
- F1: Shares issued in settlement of a performance stock award.
- F2: Shares surrendered to the issuer solely to cover tax withholding on the award.
- F3: The 5,558-share sale was effected under a Rule 10b5-1 plan.
- F4: Some plan-related shares may be held/allocated via the company’s 401(k)/deferred comp plans per plan administrator.
- Filing: Reported on 2026-03-06 for transactions on 2026-03-04–03-05; appears timely based on the filing and report dates.
Context
This was a compensation-related settlement (performance shares) with a routine tax-withholding surrender and a subsequent planned sale under a 10b5-1 plan. Receiving an award and immediately surrendering part of it to cover taxes is a common administrative step; the open-market sale was pre-arranged under a trading plan. These transactions are clerical/compensation-related rather than an unsolicited market-timing purchase by the insider.
Insider Transaction Report
- Tax Payment
Common Stock
[F2]2026-03-04$204.86/sh−5,806$1,189,417→ 72,680 total - Award
Common Stock
[F1]2026-03-04$204.86/sh+11,364$2,328,029→ 78,486 total - Sale
Common Stock
[F3]2026-03-05$206.21/sh−5,558$1,146,115→ 67,122 total
- 4,502(indirect: By 401(k))
Common Stock
[F4]
Footnotes (4)
- [F1]Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).
- [F2]Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.
- [F3]This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
- [F4]These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.